Effect of Electroconvulsive Therapy on Retinal Nerve Fiber Layer Thickness in Depression
Can Electroconvulsive Therapy Alter Retinal Nerve Fiber Layer Thickness of Patients With Depression
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Mehmet D Güleken, MD
- Phone Number: +905063282603
- Email: mdguleken@hotmail.com
Study Contact Backup
- Name: Hasan Öncül, MD
- Phone Number: +905357624011
- Email: hasan.oncul@hotmail.com
Study Locations
-
-
-
Diyarbakır, Turkey, 21070
- Recruiting
- Sağlık Bilimleri Üniversitesi Gazi Yaşargil Tranining and Research Hospital
-
Contact:
- Mehmet D Güleken, MD
- Phone Number: +905063282603
- Email: mdguleken@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subject diagnosed as unipolar depression
- Subject with depression to be treated with electroconvulsive therapy
- Subject with depression having a Standardized Mini Mental Test score of >23
Exclusion Criteria:
- Any comorbid psychiatric condition (including alcohol / substance use)
- Having any major neurological (i.e.: cerebrovascular disease, multiple sclerosis, etc.) disease
- Having any major medical (i.e.: diabetes mellitus, myocardial infarction, etc.) disease
- History of or having any ocular trauma, disease or surgery, any retinal disease, refraction defect
- To be treated with electroconvulsive therapy in the last 6 months
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Depression
Subjects with depression treated with electroconvulsive therapy
|
Thymatron System IV electroconvulsive therapy device
|
|
Healthy
Healthy subjects
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of retinal nerve fiber layer thickness
Time Frame: About 4 weeks
|
Changes of retinal nerve fiber layer thickness of subjects with depression before and after electroconvulsive therapy
|
About 4 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Mehmet D Güleken, MD, Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Publications and helpful links
General Publications
- Gazdag G, Ungvari GS. Electroconvulsive therapy: 80 years old and still going strong. World J Psychiatry. 2019 Jan 4;9(1):1-6. doi: 10.5498/wjp.v9.i1.1. eCollection 2019 Jan 4.
- Ousdal OT, Argyelan M, Narr KL, Abbott C, Wade B, Vandenbulcke M, Urretavizcaya M, Tendolkar I, Takamiya A, Stek ML, Soriano-Mas C, Redlich R, Paulson OB, Oudega ML, Opel N, Nordanskog P, Kishimoto T, Kampe R, Jorgensen A, Hanson LG, Hamilton JP, Espinoza R, Emsell L, van Eijndhoven P, Dols A, Dannlowski U, Cardoner N, Bouckaert F, Anand A, Bartsch H, Kessler U, Oedegaard KJ, Dale AM, Oltedal L; GEMRIC. Brain Changes Induced by Electroconvulsive Therapy Are Broadly Distributed. Biol Psychiatry. 2020 Mar 1;87(5):451-461. doi: 10.1016/j.biopsych.2019.07.010. Epub 2019 Jul 25.
- Pan J, Zhou Y, Xiang Y, Yu J. Retinal nerve fiber layer thickness changes in Schizophrenia: A meta-analysis of case-control studies. Psychiatry Res. 2018 Dec;270:786-791. doi: 10.1016/j.psychres.2018.10.075. Epub 2018 Oct 30.
- Mutlu U, Colijn JM, Ikram MA, Bonnemaijer PWM, Licher S, Wolters FJ, Tiemeier H, Koudstaal PJ, Klaver CCW, Ikram MK. Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study. JAMA Neurol. 2018 Oct 1;75(10):1256-1263. doi: 10.1001/jamaneurol.2018.1563.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MDGuleken
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.